Targeted antiviral prophylaxis of flu case contacts could successfully contain pandemic influenza


Emory dynamic simulation model shows targeted use of antiviral agents might be effective intervention until adequate supplies of vaccine become available

ATLANTA – In a future outbreak of pandemic influenza, such as the three pandemics that sickened millions and killed hundreds of thousands of people during the 20th century, supplies of flu vaccine might not be available quickly enough to contain the spread of disease. However, according to research by biostatisticians in Emory University's Rollins School of Public Health, many thousands of deaths could be prevented if antiviral agents were given to the close contacts of those with suspected cases of flu until adequate supplies of vaccine could be manufactured and distributed. The results of the research by Emory professors of biostatistics Ira Longini, Jr,, PhD, and M. Elizabeth Halloran, MD, DSc, and their colleagues Azhar Nizam, MS, and Yang Yang, BSc, will appear online on March 26, and will be published as a special article in the American Journal of Epidemiology on April 1, 2004.

The Emory scientists used a dynamic stochastic simulation model of an influenza pandemic or bioterrorist attack for an agent similar to influenza A(H2N2), which caused the Asian influenza pandemic of 1957-58 and resulted in approximately 70,000 deaths in the U.S. (A stochastic model includes elements of chance or probability). They determined that if no interventions were used in a similar pandemic, 33 percent of the population would become ill, resulting in a death rate of 0.58 per 1,000 people. If antiviral prophylaxis was given to close contacts of 80% of suspected influenza cases, however, in a strategy that the authors call "targeted antiviral prophylaxis" (TAP), the epidemic could be contained. If TAP were begun within one day of identifying suspected flu cases and used for up to eight weeks, only 2 percent of the population would become ill, and the death rate would be only 0.04 per 1,000 people. The researchers found that eight weeks of TAP would be nearly as effective as vaccinating 80 percent of the population.

"The ability to rely on targeted antiviral therapy in the case of a major public health threat from influenza would be an extremely valuable strategy, due to the characteristics of influenza pandemics," Dr. Longini said. "Epidemics are usually due to strains of flu that acquire genetic variations that differ slightly from earlier strains, while pandemics occur when there is a dramatic shift in the current flu strain. Annual flu vaccines are designed to counter the strain of flu from the previous season, and often there is insufficient time to catch up with making enough vaccine to counter the first wave of a new outbreak. Manufacturing and distributing a vaccine to match a newly identified strain can take six to eight months."

Although the surveillance and containment strategy (i.e., isolation of cases and quarantine of close contacts) was recently used to successfully contain the spread of severe acute respiratory syndrome (SARS), influenza has a much shorter incubation period (1.9 days as opposed to 6.4 days), and has a much broader range of clinical illness, from asymptomatic to primary pneumonia. Thus the surveillance and containment strategy is unlikely to work in containing an influenza epidemic.

"Because surveillance and containment would be an ineffective strategy to contain an influenza epidemic, stockpiling antiviral drugs, along with a well-planned distribution strategy, could be an effective first line of defense while an adequate supply of vaccine is being produced to counter subsequent waves of infection," Dr. Longini explained.

Scientists already know that antiviral drugs can be used prophylactically to help prevent infection after exposure, to reduce the probability of clinical illness after infection, and to reduce the probability of transmission by infected individuals, as well as used therapeutically to reduce clinical illness and transmission after infection. The Emory model simulates what the population level effects would be for various TAP strategies. These include the indirect effects to people not directly receiving the intervention. The model population consisted of people whose characteristics simulated the age distribution and approximate household sizes from the U.S. 2000 Census. The spread of influenza was simulated through measuring typical numbers of close and casual contacts during the course of a day.

Although the researchers acknowledged that vaccination, if available, would be the most effective strategy to prevent an epidemic, they found that using TAP for up to four weeks would be almost as effective as vaccinating 50 percent of the entire population. TAP when used for up to eight weeks would be nearly as effective as vaccinating 80 percent of the entire population. If only limited quantities of vaccine were available, they found that vaccinating 80 percent of children younger than 19 would be nearly as effective as vaccinating 80 percent of the entire population.

"Although we know that vaccination is the best intervention for influenza, vaccine supplies may be limited," Dr. Halloran emphasized. "Using 80 percent TAP for six to eight weeks is almost as effective as vaccinating 80 percent of the entire population, but even given more limited supplies of antiviral agents, TAP for just one week could prevent millions of cases of influenza and save thousands of lives."

The researchers also addressed possible concerns about the emergence of drug-resistant influenza due to the widespread use of antivirals. Two classes of antiviral drugs– adamantanes and neuraminidase inhibitors – currently are used for influenza, either therapeutically or prophylactically. Drug resistance developing from prophylactic use of these agents has been shown to be much lower than for therapeutic use. The Emory scientists emphasize that the properties of neuraminidase inhibitors would lead to minimal spread of resistant strains with the TAP strategy, suggesting that this class of antiviral drug would be the best to stockpile for such use, followed by adamantanes.

"Effectiveness of the TAP strategy is based on systematic identification of index cases of influenza, and could be particularly effective in institutional settings such as schools, nursing homes and the workplace, and also for health care workers and first responders," Dr. Longini said. "If the logistical and financial details can be managed, the targeted use of antiviral drugs would be an effective first-line strategy for containing a pandemic influenza epidemic."

Source: Eurekalert & others

Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
    Published on All rights reserved.



I've wrestled with reality for 35 years, Doctor, and I'm happy to state I finally won out over it.
-- Mary Chase